What’s New
- Study Suggests a Healthy Diet May Help Keep Low Grade Prostate Cancer From Progressing to More Dangerous States During Active Surveillance
- FDA Receives NDA for 3-Month Version of Leuprolide Mesylate for Advanced Prostate Cancer
- Circulating Tumor Cells May Predict Prostate Cancer Survival
- Exercise Benefits In Prostate Cancer Active Surveillance
- PARP Inhibitors in Metastatic Prostate Cancer